100700 — Sewoon Medical Co Balance Sheet
0.000.00%
- KR₩105bn
- KR₩22bn
- KR₩60bn
- 76
- 77
- 16
- 60
Annual balance sheet for Sewoon Medical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | ARS | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 34,662 | 51,852 | 57,003 | 75,710 | 86,098 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 13,127 | 12,118 | 13,396 | 12,922 | 12,777 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 68,111 | 82,819 | 91,588 | 107,929 | 119,381 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 37,623 | 38,184 | 37,884 | 35,571 | 34,328 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 109,527 | 124,725 | 132,479 | 146,612 | 156,848 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 5,544 | 8,160 | 6,697 | 8,297 | 7,010 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Liabilities | 7,551 | 10,590 | 9,474 | 11,455 | 10,730 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 101,976 | 114,135 | 123,005 | 135,157 | 146,118 |
Total Liabilities & Shareholders' Equity | 109,527 | 124,725 | 132,479 | 146,612 | 156,848 |
Total Common Shares Outstanding |